Aclaris therapeutics to participate in the h.c. wainwright inflammation & immunology virtual conference

Wayne, pa., june 26, 2025 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it will provide a corporate presentation during the h.c. wainwright inflammation & immunology virtual conference.
ACRS Ratings Summary
ACRS Quant Ranking